Kun-Liang Feng

Statistics

Publications

Citations

132

H-Index

Active since

2020

Affiliations

First Affiliated Hospital of Guangzhou University of Chinese Medicine(Current)

Guangzhou University of Chinese Medicine

Kun-Liang Feng is an author at First Affiliated Hospital of Guangzhou University of Chinese Medicine specializing in molecular oncology, liver metastasis, and oncology.

Publications per year

2020–2025

Publications

Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma

Chongkai Fang, Silin Liu, Kun-Liang Feng et al. · Scientific Reports · 2022 · 49 citations · Full text

Medicine, Bioinformatics, Oncology +17

CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p/SLC7A11 axis

Ying Zhang, Ruiwei Yao, Mingyi Li et al. · Molecular Cancer · 2025 · 33 citations · Full text

Medicine, Cancer Biology, Oncology +16

Erratum: microRNAs carried by exosomes promote epithelial-mesenchymal transition and metastasis of liver cancer cells.

Chunfeng Xie, Kun-Liang Feng, Dongying Cui et al. · PubMed · 2020 · 14 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Jianpi Huayu decoction inhibits the epithelial–mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling

Chunfeng Xie, Kun-Liang Feng, Ji-Nan Wang et al. · Journal of Ethnopharmacology · 2022 · 14 citations

Life Sciences, Molecular Biology, Oncology +17

JPHYD Inhibits miR-21-5p/Smad7-Mediated Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells

Li-Hua Liu, Chongkai Fang, Fu-Cheng Ge et al. · Journal of Oncology · 2022 · 12 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 6